Astrana Health Statistics
Total Valuation
Astrana Health has a market cap or net worth of $1.95 billion. The enterprise value is $2.05 billion.
| Market Cap | 1.95B |
| Enterprise Value | 2.05B |
Important Dates
The next estimated earnings date is Wednesday, August 28, 2024, before market open.
| Earnings Date | Aug 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Astrana Health has 48.89 million shares outstanding. The number of shares has decreased by -3.50% in one year.
| Shares Outstanding | 48.89M |
| Shares Change (YoY) | -3.50% |
| Shares Change (QoQ) | -4.91% |
| Owned by Insiders (%) | 26.37% |
| Owned by Institutions (%) | 47.68% |
| Float | 35.96M |
Valuation Ratios
The trailing PE ratio is 30.23 and the forward PE ratio is 26.14.
| PE Ratio | 30.23 |
| Forward PE | 26.14 |
| PS Ratio | 1.34 |
| Forward PS | 1.05 |
| PB Ratio | 2.99 |
| P/FCF Ratio | 37.20 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.22, with an EV/FCF ratio of 39.04.
| EV / Earnings | 32.80 |
| EV / Sales | 1.41 |
| EV / EBITDA | 14.22 |
| EV / EBIT | 17.79 |
| EV / FCF | 39.04 |
Financial Position
The company has a current ratio of 1.52, with a Debt / Equity ratio of 0.66.
| Current Ratio | 1.52 |
| Quick Ratio | 1.47 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 3.01 |
| Debt / FCF | 8.27 |
| Interest Coverage | 5.63 |
Financial Efficiency
Return on equity (ROE) is 10.30% and return on invested capital (ROIC) is 5.61%.
| Return on Equity (ROE) | 10.30% |
| Return on Assets (ROA) | 5.90% |
| Return on Capital (ROIC) | 5.61% |
| Revenue Per Employee | $807,652 |
| Profits Per Employee | $34,678 |
| Employee Count | 1,800 |
| Asset Turnover | 1.37 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Astrana Health has paid $32.21 million in taxes.
| Income Tax | 32.21M |
| Effective Tax Rate | 34.04% |
Stock Price Statistics
The stock price has increased by +28.63% in the last 52 weeks. The beta is 1.11, so Astrana Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | +28.63% |
| 50-Day Moving Average | 39.44 |
| 200-Day Moving Average | 36.98 |
| Relative Strength Index (RSI) | 48.59 |
| Average Volume (20 Days) | 195,093 |
Short Selling Information
The latest short interest is 2.68 million, so 5.49% of the outstanding shares have been sold short.
| Short Interest | 2.68M |
| Short Previous Month | 2.74M |
| Short % of Shares Out | 5.49% |
| Short % of Float | 7.46% |
| Short Ratio (days to cover) | 16.86 |
Income Statement
In the last 12 months, Astrana Health had revenue of $1.45 billion and earned $62.42 million in profits. Earnings per share was $1.32.
| Revenue | 1.45B |
| Gross Profit | 241.07M |
| Operating Income | 92.38M |
| Pretax Income | 94.63M |
| Net Income | 62.42M |
| EBITDA | 143.94M |
| EBIT | 115.05M |
| Earnings Per Share (EPS) | $1.32 |
Balance Sheet
The company has $337.29 million in cash and $433.57 million in debt, giving a net cash position of -$96.29 million or -$1.97 per share.
| Cash & Cash Equivalents | 337.29M |
| Total Debt | 433.57M |
| Net Cash | -96.29M |
| Net Cash Per Share | -$1.97 |
| Equity (Book Value) | 653.49M |
| Book Value Per Share | 13.37 |
| Working Capital | 183.54M |
Cash Flow
In the last 12 months, operating cash flow was $66.48 million and capital expenditures -$14.05 million, giving a free cash flow of $52.44 million.
| Operating Cash Flow | 66.48M |
| Capital Expenditures | -14.05M |
| Free Cash Flow | 52.44M |
| FCF Per Share | $0.95 |
Margins
Gross margin is 16.58%, with operating and profit margins of 6.35% and 4.29%.
| Gross Margin | 16.58% |
| Operating Margin | 6.35% |
| Pretax Margin | 6.51% |
| Profit Margin | 4.29% |
| EBITDA Margin | 9.90% |
| EBIT Margin | 7.91% |
| FCF Margin | 3.61% |
Dividends & Yields
Astrana Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.50% |
| Shareholder Yield | 3.50% |
| Earnings Yield | 3.20% |
| FCF Yield | 2.69% |
Analyst Forecast
The average price target for Astrana Health is $47.75, which is 19.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $47.75 |
| Price Target Difference | 19.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 13.11% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 27, 2015. It was a reverse split with a ratio of 1:10.
| Last Split Date | Apr 27, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
Astrana Health has an Altman Z-Score of 3.48 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.48 |
| Piotroski F-Score | 6 |